# Steven Kearnes

[Education](#education) | [Experience](#experience) | [Community](#community-contributions) | [Publications](#publications) | [Talks](#talks)

## Education

### Stanford University
2011&ndash;2016

* PhD Structural Biology
* Adviser: Vijay Pande
* Internships at __Google__ and __Vertex Pharmaceuticals__
* [Dissertation](https://searchworks.stanford.edu/view/11849467): "Finding Needles in a Haystack: Molecular Similarity and Machine Learning for Drug Discovery Applications"

### Brigham Young University 
2004, 2007&ndash;2011

* BS Biochemistry _magna cum laude_
* Advisers: Steven Herron, Barry Willardson

## Experience

### Relay Therapeutics
2021&ndash;Present, Director of AI Research

### Google
2016&ndash;2021, Software Engineer / Research Scientist / Senior Research Scientist

[Google Applied Science](https://research.google/teams/applied-science/)

## Community Contributions

* Governing Committee, [Open Reaction Database](https://open-reaction-database.org) (2019&ndash;Present)
* Guest Editor, ["Artificial Intelligence in Drug Discovery"](https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01077), _Journal of Medicinal Chemistry_ Special Issue (2020)
* Editorial Board, [_Artificial Intelligence in the Life Sciences_](https://www.sciencedirect.com/journal/artificial-intelligence-in-the-life-sciences) (2021&ndash;Present)

## Publications

[Google Scholar](https://scholar.google.com/citations?user=LxJEYK4AAAAJ&hl=en)

### Research highlights:

* Large-Scale Machine Learning for Drug Discovery ([Google AI Blog](https://ai.googleblog.com/2015/03/large-scale-machine-learning-for-drug.html), 2 March 2015)
* Neural Networks for Drug Discovery: A Work in Progress ([In the Pipeline](https://blogs.sciencemag.org/pipeline/archives/2015/03/04/neural_networks_for_drug_discovery_a_work_in_progress), 4 March 2015)
* Unlocking the "Chemome" with DNA-Encoded Chemistry and Machine Learning ([Google AI Blog](https://ai.googleblog.com/2020/06/unlocking-chemome-with-dna-encoded.html), 11 June 2020)
* Machine Learning On Top of DNA Encoded Libraries ([In the Pipeline](https://blogs.sciencemag.org/pipeline/archives/2020/06/16/machine-learning-on-top-of-dna-encoded-libraries), 16 June 2020)

### 2022

* Goldman B, __Kearnes S__, Kramer T, Riley P, Walters WP. Defining Levels of Automated Chemical Design. _J Med Chem_. ([JMC](https://doi.org/10.1021/acs.jmedchem.2c00334))

### 2021

* __Kearnes SM__, Maser MR, Wleklinski M, Kast A, Doyle AG, Dreher SD, Hawkins JM, Jensen KF, Coley CW. The Open Reaction Database. _JACS_ 143(45), 18820-18826. ([JACS](https://doi.org/10.1021/jacs.1c09820))

### 2020

* Moshiri J, Constant DA, Liu B, Mateo R, __Kearnes S__, Novick P, et al. A Targeted Computational Screen of the SWEETLEAD Database Reveals FDA-Approved Compounds with Anti-Dengue Viral Activity. _mBio_ 11. ([mBio](https://doi.org/10.1128/mBio.02839-20))
* McCloskey K, Sigel EA, __Kearnes S__, Xue L, Tian X, Moccia D, et al. Machine Learning on DNA-Encoded Libraries: A New Paradigm for Hit Finding. _J Med Chem_ 63, 8857–8866. ([JMC](https://doi.org/10.1021/acs.jmedchem.0c00452), [arXiv](https://arxiv.org/pdf/2009.00707.pdf))
* Bajorath J, __Kearnes S__, Walters WP, Meanwell NA, Georg GI, Wang S. Artificial Intelligence in Drug Discovery: Into the Great Wide Open. _J Med Chem_ 63, 8651–8652. ([JMC](https://doi.org/10.1021/acs.jmedchem.0c01077))
* Sun R, Dai H, Li L, __Kearnes S__, Dai B. Energy-Based View of Retrosynthesis. ([arXiv](https://arxiv.org/pdf/2007.13437.pdf))
* __Kearnes S__. Pursuing a Prospective Perspective. _Trends in Chemistry_ 3, 77–79. ([TiC](https://doi.org/10.1016/j.trechm.2020.10.012), [arXiv](https://arxiv.org/pdf/2009.00707.pdf))

### 2019

* __Kearnes S__, Li L, Riley P. Decoding Molecular Graph Embeddings with Reinforcement Learning. ICML 2019 Workshop on Learning and Reasoning
with Graph-Structured Data. ([arXiv](http://arxiv.org/abs/1904.08915))
* Bajorath J, __Kearnes S__, Walters WP, Georg GI, Wang S. The Future is Now: Artificial Intelligence in Drug Discovery. _J Med Chem_ 62, 5249. ([JMC](https://doi.org/10.1021/acs.jmedchem.9b00805))
* Zhou Z, __Kearnes S__, Li L, Zare RN, Riley P. Optimization of Molecules via Deep Reinforcement Learning. _Scientific Reports_ 9, 10752. ([SciRep](https://doi.org/10.1038/s41598-019-47148-x))

### 2018

* Thomas N, Smidt T, __Kearnes S__, Yang L, Li L, Kohlhoff K, et al. Tensor Field Networks: Rotation- and Translation-Equivariant Neural Networks for 3D Point Clouds. ([arXiv](http://arxiv.org/abs/1802.08219))

### 2017

* Faber FA, Hutchison L, Huang B, Gilmer J, Schoenholz SS, Dahl GE, Vinyals O, __Kearnes S__, et al. Prediction Errors of Molecular Machine Learning Models Lower than Hybrid DFT Error. _J Chem Theory Comput_ 13, 5255–5264. ([JCTC](https://doi.org/10.1021/acs.jctc.7b00577), [arXiv](https://arxiv.org/pdf/1702.05532.pdf))

### 2016

* __Kearnes S__, McCloskey K, Berndl M, Pande V, Riley P. Molecular Graph Convolutions: Moving Beyond Fingerprints. _J Comput Aided Mol Des_ 30, 595–608. ([JCAMD](https://doi.org/10.1007/s10822-016-9938-8), [arXiv](https://arxiv.org/pdf/1603.00856.pdf))
* __Kearnes S__, Pande V. ROCS-Derived Features for Virtual Screening. _J Comput Aided Mol Des_ 30, 609–617. ([JCAMD](https://doi.org/10.1007/s10822-016-9959-3), [arXiv](https://arxiv.org/pdf/1606.01822.pdf))
* __Kearnes S__, Goldman B, Pande V. Modeling Industrial ADMET Data with Multitask Networks. ([arXiv](http://arxiv.org/abs/1606.08793))
* T. McGibbon R, X. Hernández C, P. Harrigan M, __Kearnes S__, M. Sultan M, Jastrzebski S, et al. Osprey: Hyperparameter Optimization for Machine Learning. _J Open Source Softw_ 1, 34. ([JOSS](https://doi.org/10.21105/joss.00034))

### 2015

* Ramsundar B, __Kearnes S__, Riley P, Webster D, Konerding D, Pande V. Massively Multitask Networks for Drug Discovery. ([arXiv](http://arxiv.org/abs/1502.02072))

### 2014

* __Kearnes SM__, Haque IS, Pande VS. SCISSORS: Practical Considerations. _J Chem Inf Model_ 54, 5–15. ([JCIM](https://doi.org/10.1021/ci400264f), [PubMed](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207653/))

## Talks

### 2022

* C-CAS Semi-Annual Meeting (11 March; remote)
* Harvard APMTH 216: Inverse Problems in Science and Engineering (6 April)
* Harvard COMPSCI 282R: Topics in Machine Learning: Advancements in Probabilistic ML, Programming Models for ML, Causality (8 April)

### 2021

* Boston Area Group for Informatics and Modeling (26 January; [YouTube](https://youtu.be/6IDKEIln1JM))
* SynTech CDT, University of Cambridge, Cambridge, UK (12 May; remote)
* NIH Virtual Workshop on Reaction Informatics (19 May; [video](https://nci.rev.vbrick.com/sharevideo/cf6e33d3-12bb-4fca-90ae-72877bacc6a4))
* Cambridge Cheminformatics Meeting (2 June; [YouTube](https://youtu.be/T-AtZgGanAk?t=251))
* VISTA Symposium on Artificial-Intelligence and Data-Science assisted Synthesis (16 July; remote)

### 2020

* Relay Therapeutics, Cambridge, MA (25 Februrary)
* AI Powered Drug Discovery and Manufacturing Conference, MIT, Cambridge, MA (27 February; panel discussion)
* Insitro, South San Francisco, CA (12 March)
* Harvard APMTH 216: Inverse Problems in Science and Engineering (3 April; remote)
* Nurix Therapeutics (29 June; remote)
* RDKit UGM (7 October; [YouTube](https://youtu.be/UyHVwJUBDIk))
* Bay Area COMP Together (17 November; remote lightning talk)

### 2019

* Gordon Research Conference: Computer Aided Drug Design, West Dover, VT (16 July)

### 2018

* OpenEye CUP, Santa Fe, NM (7 March)
* Central New Jersey Data Science Meetup, Monmouth Junction, NJ (21 July; remote)

### 2017

* O. Anatole von Lilienfeld research group, University of Basel, Basel, Switzerland (6 April)
* Novartis Institutes for BioMedical Research, Basel, Switzerland (6 April)
* NSF CHE Workshop: Framing the Role of Big Data and Modern Data Science in Chemistry, Arlington, VA (18 April)
* Vertex Pharmaceuticals, Boston, MA (1 May)
* Vertex Pharmaceuticals, Abingdon, UK (23 May; remote)
* SPARK at Stanford (4 October; panel discussion)

### 2016

* GTCBio Drug Design and Medicinal Chemistry Conference, Boston, MA (12 September)

### 2015

* Gordon Research Seminar: Computer Aided Drug Design, West Dover, VT (18 July)
* Novartis Institutes for Biomedical Research, Cambridge, MA (6 August; remote)
* National Institute of Environmental Health Sciences, Research Triangle Park, NC (16 September; remote)
* Brigham Young University Department of Chemistry and Biochemistry, Provo, UT (23 September)

### 2014

* F5 Networks, Spokane, WA (23 June)
* Vertex Pharmaceuticals, Boston, MA (6 November)
* Williams College Physics Department, Williamstown, MA (7 November)
